Skip to main content
大禹生物 logo

大禹生物 — Investor Relations & Filings

Ticker · 920970 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 384 across all filing types
Latest filing 2023-12-25 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920970

About 大禹生物

http://www.sxdysw.cn/

Shanxi Dayu Biological Assistance Co., Ltd. specializes in the research, development, and production of advanced animal nutrition and health solutions. The company focuses on the manufacturing of feed additives, micro-ecological preparations, and biological feed products. Its core portfolio includes probiotics, enzyme preparations, and functional premixes designed to enhance livestock immunity, improve feed conversion rates, and promote sustainable farming practices. By leveraging biotechnology, the firm provides integrated solutions for the aquaculture and animal husbandry sectors, emphasizing scientific innovation and product quality to support the modernization of the agricultural supply chain.

Recent filings

Filing Released Lang Actions
第三届董事会第十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 13th meeting of the 3rd Board of Directors of Shanxi Dayu Biological Engineering Co., Ltd. It details meeting attendance, agenda items, voting results, and references to related announcements on the stock exchange platform. The content focuses on board meeting decisions and procedural details rather than financial results or reports. There is no indication of full financial statements or detailed management discussion. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2023-12-25 Chinese
安信证券股份有限公司关于山西大禹生物工程股份有限公司预计2024年日常性关联交易的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from a sponsoring securities company (安信证券股份有限公司) regarding the anticipated 2024 routine related-party transactions of 山西大禹生物工程股份有限公司. It includes extensive information on the nature, pricing, fairness, necessity, and impact of these related-party transactions, as well as the approval process by the board and independent directors. The document is regulatory in nature, focusing on compliance with securities issuance and listing rules, and it provides an audit opinion on the related-party transactions for the upcoming year. It is not a full annual or interim financial report, nor is it a simple announcement or certification. It is a specialized audit or review report on related-party transactions, which fits best under the category of Audit Report / Information (AR). The document length (6730 characters) and content depth support this classification with high confidence.
2023-12-25 Chinese
关于预计2024年日常性关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanxi Dayu Bioengineering Co., Ltd. regarding the expected related party transactions for the year 2024. It includes detailed information about the nature, amounts, and counterparties of these transactions, as well as the approval process by the board and independent directors. The document is not a full financial report but a specific disclosure about related party transactions expected in the upcoming year, which is a common type of regulatory announcement in Chinese markets. It does not contain comprehensive financial statements or management discussion and analysis, nor is it a voting result or a meeting presentation. It is a regulatory announcement about expected related party transactions, fitting best under the category of Regulatory Filings (RNS). The document length (5650 characters) and content confirm it is not merely a report publication announcement but a substantive disclosure. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2023-12-25 Chinese
2023 年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the company's third extraordinary general meeting of shareholders in 2023. It details the meeting date, attendance, agenda items, voting results, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the official results of shareholder votes on various proposals, including amendments to company bylaws and management systems. There is no financial data or report content, but rather the formal announcement of voting outcomes from a shareholders' meeting. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is about 4,521 characters, which is sufficient for a detailed voting results announcement. Therefore, the correct classification is DVA with high confidence.
2023-11-28 Chinese
上海市锦天城律师事务所关于山西大禹生物工程股份有限公司 2023 年第三次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening and proceedings of the 2023 third extraordinary general meeting (临时股东大会) of Shanxi Dayu Biological Engineering Co., Ltd. It details the legality of the meeting's convening, the qualifications of attendees, the voting procedures, and the results of the votes on various amendments to company rules and regulations. The document focuses on the official voting results and the legality of the shareholder meeting resolutions. It is not a full annual or interim report, nor is it a presentation or management discussion. It is a formal announcement of the voting results from a shareholder meeting. Therefore, the document best fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is over 5,000 characters and contains detailed voting results, supporting this classification with high confidence.
2023-11-28 Chinese
公司章程
Governance Information Classification · 100% confidence The document is titled as the "Company Articles of Association" (公司章程) for 山西大禹生物工程股份有限公司 dated November 2023. It contains detailed chapters on company governance, shareholder rights, board of directors, management, financial accounting, audit, shareholder meetings, and other corporate governance matters. The content is a comprehensive set of internal rules and regulations governing the company’s organization, shareholder meetings, board structure, and management responsibilities. It is not a financial report, earnings release, or announcement but a governance document outlining the company’s internal rules and governance practices. Therefore, the document fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance document, not a brief announcement or summary.
2023-11-28 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.